184 related articles for article (PubMed ID: 1746799)
1. The hepatorenal syndrome in liver transplant recipients.
Seu P; Wilkinson AH; Shaked A; Busuttil RW
Am Surg; 1991 Dec; 57(12):806-9. PubMed ID: 1746799
[TBL] [Abstract][Full Text] [Related]
2. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience.
Shusterman B; Mchedishvili G; Rosner MH
Transplant Proc; 2007 Jun; 39(5):1496-500. PubMed ID: 17580171
[TBL] [Abstract][Full Text] [Related]
3. Impact of pretransplant renal function on survival after liver transplantation.
Gonwa TA; Klintmalm GB; Levy M; Jennings LS; Goldstein RM; Husberg BS
Transplantation; 1995 Feb; 59(3):361-5. PubMed ID: 7871566
[TBL] [Abstract][Full Text] [Related]
4. Does hepatorenal syndrome affect the result of liver transplantation? Clinical observations.
Park I; Moon E; Hwang JA; Yu S; Kim BW; Wang HJ; Shin GT; Kim H
Transplant Proc; 2010 Sep; 42(7):2563-6. PubMed ID: 20832544
[TBL] [Abstract][Full Text] [Related]
5. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT).
Ruiz R; Barri YM; Jennings LW; Chinnakotla S; Goldstein RM; Levy MF; McKenna GJ; Randall HB; Sanchez EQ; Klintmalm GB
Liver Transpl; 2007 Jun; 13(6):838-43. PubMed ID: 17539003
[TBL] [Abstract][Full Text] [Related]
6. Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation.
Ellis D; Avner ED
Clin Nephrol; 1986 Jun; 25(6):295-303. PubMed ID: 3524924
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation.
Lafayette RA; Paré G; Schmid CH; King AJ; Rohrer RJ; Nasraway SA
Clin Nephrol; 1997 Sep; 48(3):159-64. PubMed ID: 9342487
[TBL] [Abstract][Full Text] [Related]
8. Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation.
López Lago AM; Fernández Villanueva J; García Acuña JM; Paz ES; Vizoso EF; Pérez EV
Transplant Proc; 2007 Sep; 39(7):2318-9. PubMed ID: 17889176
[TBL] [Abstract][Full Text] [Related]
9. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.
Skagen C; Einstein M; Lucey MR; Said A
J Clin Gastroenterol; 2009 Aug; 43(7):680-5. PubMed ID: 19238094
[TBL] [Abstract][Full Text] [Related]
11. Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months.
Storm C; Bernhardt WM; Schaeffner E; Neuhaus R; Pascher A; Neuhaus P; Hasper D; Frei U; Kahl A
Transplant Proc; 2007 Mar; 39(2):544-6. PubMed ID: 17362778
[TBL] [Abstract][Full Text] [Related]
12. Long-term analysis of combined liver and kidney transplantation at a single center.
Ruiz R; Kunitake H; Wilkinson AH; Danovitch GM; Farmer DG; Ghobrial RM; Yersiz H; Hiatt JR; Busuttil RW
Arch Surg; 2006 Aug; 141(8):735-41; discussion 741-2. PubMed ID: 16924080
[TBL] [Abstract][Full Text] [Related]
13. Extended criteria donors in liver transplant candidates with hepatorenal syndrome.
Briceño J; Ciria R; de la Mata M; Montero JL; Rufián S; López-Cillero P
Clin Transplant; 2011; 25(3):E257-63. PubMed ID: 21303415
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation.
Wong F; Leung W; Al Beshir M; Marquez M; Renner EL
Liver Transpl; 2015 Mar; 21(3):300-7. PubMed ID: 25422261
[TBL] [Abstract][Full Text] [Related]
15. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
16. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
von Kalckreuth V; Glowa F; Geibler M; Lohse AW; Denzer UW
Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation.
Chok KS; Fung JY; Chan SC; Cheung TT; Sharr WW; Chan AC; Fan ST; Lo CM
Liver Transpl; 2012 Jul; 18(7):779-85. PubMed ID: 22290625
[TBL] [Abstract][Full Text] [Related]
18. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
19. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P; Kumar A; Shrama BC; Sarin SK
Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic liver transplantation and renal function; outcome of hepatorenal syndrome and trial of verapamil for renal protection in nonhepatorenal syndrome.
Gonwa TA; Goldstein M; Holman M; Husberg BS; Klintmalm GB
Transplant Proc; 1993 Apr; 25(2):1891-2. PubMed ID: 8470216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
